Richter shareholders approve HUF 100 per-share dividend
Photo by LaMography / Moni Lazar
Shareholders of Hungarian drugmaker Gedeon Richter approved a proposal to pay a HUF 100 per-share dividend on last yearʼs earnings at the firmʼs annual general meeting on Wednesday, according to media reports. The dividend fund comes to HUF 18.637 billion.
Last year, shareholders approved a HUF 68 per-share dividend on 2017 earnings.
When determining the dividend, an adjustment was made for losses deriving from regulatory concerns over a potential link with liver injury through use of Richterʼs uterine fibroid drug Esmya, noted a report on business news site mfor.hu.
The consolidated report submitted to the AGM in accordance with International Financial Reporting Standards (IFRS) reveals that the Richter group posted after-tax profit of HUF 36.193 bln in 2018, with a balance sheet footing of HUF 797.883 bln.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.